Related Experiment Video

Updated: Mar 19, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.4K

Chronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome

Jois Preeti, Mebazaa Alexandre, Iyngkaran Pupalan

  • 1Department of Nephrology Dialysis & Transplantation International Renal Research Institute (IRRIV) San Bortolo Hospital Viale Rodolfi, 37 36100 Vicenza, Italy. cronco@goldnet.it.

Current Cardiology Reviews
|June 10, 2016
PubMed

Insights

Cardiorenal syndrome (CRS) is increasingly prevalent. Type 2 CRS, where renal impairment follows heart failure, significantly worsens outcomes and limits treatment options.

Area of Science:

  • Cardiology
  • Nephrology
  • Cardiorenal Medicine

Background:

  • Cardiorenal syndrome (CRS) definition and classification are key advancements.
  • Type 2 CRS occurs when renal impairment is secondary to heart pathology, primarily chronic heart failure (CHF).
  • Understanding Type 2 CRS is crucial due to its rising prevalence and impact.

Purpose of the Study:

  • To discuss the significance of Type 2 CRS patients.
  • To highlight the unique pathophysiology and progression of Type 2 CRS subclasses.
  • To contextualize Type 2 CRS within a broader thematic series.

Main Methods:

  • Literature review on Cardiorenal Syndrome.
  • Analysis of existing definitions and classifications of CRS.
  • Discussion of pathophysiology and clinical implications of Type 2 CRS.

Main Results:

  • Type 2 CRS is characterized by secondary renal impairment due to heart failure.
  • Subclasses of Type 2 CRS exhibit distinct pathophysiological pathways and progression.
  • Type 2 CRS exacerbates morbidity and mortality in patients with chronic heart failure.

Conclusions:

  • Type 2 CRS represents a significant clinical challenge with limited therapeutic options.
  • Further understanding of Type 2 CRS is essential for improving patient outcomes.
  • This discussion emphasizes the importance of Type 2 CRS in the context of ongoing research.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.4K

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
565